Survey of Addiction Specialists’ Use of Medications to Treat Alcohol Use Disorder

Abstract

Objectives: Several medications have been shown to be safe and effective for treating alcohol use disorder (AUD); however, these medications are prescribed infrequently. We conducted a survey of the demographics, practice characteristics, and self-perceived knowledge, experience, and opinions of addiction specialists on the use of AUD medications and how to increase their use. Methods:We sent a 19-question survey to members of the American Society of Addiction Medicine (ASAM) and the American Academy of Addiction Psychiatry (AAAP). Results:We received a total of 395 responses from ASAM members and 194 responses from AAAP members. One hundred of the respondents were members of both organizations. The large majority of respondents (92.6%) were prescribers, and 81.6% were non-trainee physicians. The two most frequently used medications for treating AUD were oral naltrexone (27%) and long-acting naltrexone (18%). Respondents were significantly more confident in the strength of the research findings and evidence for the efficacy and safety of naltrexone than other AUD medications (p < 0.001 ). Respondents identified additional education to current providers about existing medications as the most important potential intervention to increase the use of AUD medications. Conclusions:Compared with a survey published in 2001, in 2018 the proportion of respondents who reported using naltrexone more than doubled and addiction specialists were more confident in their use of AUD medications, rating their efficacy and safety more highly. Consistent with findings from other recent studies, providing more education to practitioners about existing AUD medications may be the most effective way to increase their use.

Safety Net Provider Attitudes Toward Smoking Cessation Treatment

“…Given the higher occurrence of smoking among people with mental illness and low SES ( 6 ), along with the negative impact smoking can have on psychotropic medication efficacy ( 26 ), community mental health clinics may be an especially important setting for addressing TUD symptoms. These results, consistent with previous work in the addictions field, suggest that Los Angeles County providers as well as safety net providers in general, may benefit from additional training on how to approach diagnosis, discussions, and treatment for TUD ( 12 , 27 , 28 ). Research suggests that professional health care trainings on smoking cessation interventions prove beneficial and improve rates of professional counseling along with point prevalence of smoking among their patients ( 13 , 15 ).…”

Assessing Naltrexone Prescribing and Barriers to Initiation for Alcohol Use Disorder: A Multidisciplinary, Multisite Survey

“…Prior survey data have shown that naltrexone is the most commonly prescribed medication for AUD; therefore, we created a survey focused solely on naltrexone ( 19 – 21 ). J.G.L.…”

“…J.G.L. and R.W.K reviewed other published related surveys, clinical guidelines, and prescribing information for naltrexone that were available through the National Library of Medicine DailyMed and then developed a 12-component electronic survey that explored practitioners' perceptions and knowledge of naltrexone ( 17 , 19 – 22 ). A survey draft was reviewed by coinvestigators from the departments of internal medicine, family medicine, psychiatry, and pharmacy.…”

A Video- and Case-Based Curriculum on the Management of Alcohol Use Disorder for Internal Medicine Residents

“… 8 Addiction specialists believe that physician education about existing medications is the most important next step to increase MAUD prescribing. 9 …”